Clinical Evaluation of DCB-WH1 in Healing of Chronic Diabetic Foot Ulcers

NCT00709514 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

41

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Diabetic Foot Ulcer

Interventions

DRUG: DCB-WH1 ointment
DRUG: Placebo

Sponsor

Oneness Biotech Co., Ltd.